enkephalin, leucine and n-methyl-3,4-methylenedioxyamphetamine

enkephalin, leucine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Compan, V; Crosson, C; Daszuta, A; Hen, R; Scearce-Levie, K1
Candeletti, S; D'addario, C; Di Benedetto, M; Romualdi, P1
Belkaï, E; Marie-Claire, C; Noble, F; Scherrmann, JM1
Bastías Candia, Sdel C; Candeletti, S; Cavina, C; D'Addario, C; Di Benedetto, M; Porticella, EE; Romualdi, P1
Costa, G; Górska, AM; Gołembiowska, K; Kamińska, K; Kreiner, G; Morelli, M; Przewłocki, R; Wawrzczak-Bargieła, A1

Other Studies

5 other study(ies) available for enkephalin, leucine and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine.
    The European journal of neuroscience, 2003, Volume: 18, Issue:2

    Topics: Animals; Blotting, Northern; Brain; Enkephalins; Immunohistochemistry; Indoles; Mice; Mice, Knockout; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Agents; Serotonin Receptor Agonists

2003
Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain.
    Neuroscience, 2006, Volume: 137, Issue:1

    Topics: Animals; Blotting, Northern; Brain; Dynorphins; Enkephalins; Gene Expression; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors

2006
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
    Addiction biology, 2009, Volume: 14, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Choice Behavior; Conditioning, Classical; Enkephalins; Gene Expression; Hallucinogens; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, delta; RNA, Messenger; Social Environment; Transcription, Genetic

2009
Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:2

    Topics: Animals; Blotting, Western; Brain Stem; Cyclic AMP Response Element-Binding Protein; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nociceptin; Opioid Peptides; Phosphorylation; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Reverse Transcriptase Polymerase Chain Reaction; Serotonin; Serotonin Antagonists; Signal Transduction

2011
Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Neurotoxicity research, 2018, Volume: 33, Issue:3

    Topics: Animals; Caffeine; Central Nervous System Stimulants; Comet Assay; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enkephalins; Exploratory Behavior; Extracellular Fluid; Gene Expression Regulation; Hallucinogens; Locomotion; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Protein Precursors; Recognition, Psychology; RNA-Binding Proteins; Serotonin

2018